Although its receptor is not yet clear, the high expression of B7-H3 on the surface of tumor cells can inhibit the activation and function of T cells by binding to its potential receptors, thereby inhibiting the antitumor immune response [50]. The gene discussed is CD276; the disease is neoplasm.